Erythrocyte antioxidative enzyme activities and lipid peroxidation levels in patients with cutaneous leishmaniasis

Parasite

Volumn 10, Issue 3, 2003, Pages 277-281

  Kocyigit, A ^a   Gurel, M ^a   Ulukanligil, M ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

Antioxidative enzymes; Cutaneous leishmaniasis; Lipid peroxidation

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; ARTICLE; CELL DAMAGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LIPID PEROXIDATION; MALE; OXIDATION; SKIN LEISHMANIASIS; TISSUE INJURY;

EID: 0141957495     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/2003103277     Document Type: Article

References (25)

1. ASSREUY J., CUNHA F.Q., EPPERLEIN M., NORONHA-DUTRA A., O'DONNELL CA., LIEW F.Y. & MONCADA S. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. European Journal of Immunology, 1994, 24, 672-676.
2. BISWAS T., GHOSH D.K., MUKHERJEE N. & GHOSAL J. Lipid peroxidation of erythrocytes in visceral leishmaniasis. Journal of Parasitology, 1997, 83, 151-152.
3. CLARK I.A., HUNT H.N. & COWDEN W.B. Oxygen-derived free radicals in the pathogenesis of parasitic disease. Advances in Parasitology, 1986, 25, 1-44.
4. CILLARIE E., DIELI M., MALTASE E., MILANO S., SALERNO A. & LIEW F.Y. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-g. Journal of Immunology, 1989, 143, 2001-2005.
5. EREL O, KOCYIGIT A, BULUT V. & GUREL M.S. Reactive nitrogen and oxygen intermediates in patients with cutaneous leishmaniasis. Memórias do Instuto Oswaldo Cruz, 1999, 94, 179-183.
6. GOTH L. A simple method for determination of serum catalase activity and revision of reference range. Clinical Chim Acta, 1991, 196, 43-52.
7. GRAMICCIA M, BETTINI S. & YASAROL S. Izoenzyme characterization of leishmania isolates from human cases of cutaneous lesihmaniasis in Urfa, south-east Turkey. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1984, 78, 568-569.
8. GRYGLEWSKI R.J., PALMER R.M. & MONCADA S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 1986, 320, 454-456.
9. GUREL M.S., ULUKANLIGIL M. & OZBILGE H. Cutaneous leishmaniasis in Sanliurfa: Epidemiological and clinical features of the four years (1997-2000). International Journal of Dermatology, 2002, 41, 32-37.
10. HAMMODA N.A., NEGM A.Y., HUSSEIN E.D., EL-TEMSAHY M.M. & RASHWAN E.A. Leishmania major: leishmanicidal activity of activated macrophages by interferon gamma and tumor necrosis factor alpha. Journal of Egyptian Society of Parasitology, 1996, 26, 555-566.
11. JAIN S.K., LEVINE S.N., DUETT J. & HOLLIER B. Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism, 1990, 39, 971-975.
12. LI Y., SEVERN A., ROGERS M.V., PALMER R.M., MONCADA S. & LIEW F.Y. Catalase inhibits nitric oxide synthesis and the killing of intracellular Leishmania major in murine macrophages. European Journal of Immunology, 1992, 22, 441-446.
13. LIEW F.Y., PARKINSON C., MILLOR S., SEVERN A. & CARRIER M. Tumor necrosis factor (TNF-a) in leishmaniasis 1.TNF-a mediates host protection against cutaneous leishmaniasis. Immunology, 1990, 69, 570-573.
14. LIEW F.Y. & O'DONNEL C.A. Immunology of leishmaniasis. Advances in Parasitology, 1993, 32, 162-222.
15. MCCORD J.M. & FRIDOVICH I. Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein). Journal of Biological Chemistry, 1969, 244, 6049-6055.
16. MCCORD J.M. Human disease, free radicals, and the oxidant/antioxidant balance. Clinical Biochemistry, 1993, 26, 351-357.
17. PAGLIA D.E. & VALENTINE W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory Clinical Medicine, 1967, 70, 158-169.
18. PIRMEZ C., YAMAMURA M., UYEMURA K., PAES-OLIVEIRA M., CONCEICAO-SILVA F. & MODLIN R.L. Cytokine patterns in the pathogenesis of human leishmaniasis. Journal of Clinical Investigations, 1993, 91, 1390-1395.
19. RAZIUDDIN S., ABDALLA R.E., EL-AWAD E.H. & AL-JANADI M. Immunoregulatory and proinflammatory cytokine production in visceral and cutaneous leishmaniasis. Journal of Infectious Diseases, 1994, 170, 1037-1040.
20. REIMUND J.M., HIRTH C., KOEHL C., BAUMMAN R. & DUCLOS B. Antioxidant and immune status in active Crohn's disease. A possible relationship. Clinical Nutritien, 2000, 19, 43-48.
21. REINER N.E. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani. Journal of Immunology, 1987, 138, 1919-1925.
22. ROCKETT K.A., AWBURN M.M., COWDEN W.B. & CLARK I.A. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun, 1991, 59, 3280-3283.
23. RUBANYI G.M. & VANHOUTTE P.M. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. American Journal of Physiology, 1986, 250, 815-821.
24. VAN ASBECK B.S., HOIDAL J., VERCELLOTTI G.M., SCHWARTZ B.A., MOLDOW C.F. & ACOB H.S. Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: role of red cell glutathione. Science, 1985, 227, 756-759.
25. VON KOMPEN E.J. & ZILJLSTRA W.G. Standardization of hemoglobinometry. II. The hemoglobincyanide method. Clinical Chim Acta, 1961, 6, 538-544.